LSIPR 50 2018: Stephen Knight


Stephen Knight was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.


Name: Stephen Knight

Organisation: F Prime Capital Partners

Stephen Knight, LSIPR 50, LSIPR 50 2018, F Prime Capital Partners, pharmaceutical, biotechnology, CRISPR, Caribou Biosciences, Menlo Therapeutics